Cargando…

The Efficacy of Encapsulated Gamma-Cyclodextrin/Tributyrin on Growth and Inflammation in a Dextran Sodium Sulfate-Challenge Piglet Model

OBJECTIVES: Inflammatory bowel diseases are common in adults, and their incidence is increasing in children. Butyrate, a short chain fatty acid, can improve gut health, but its bitterness limits incorporation into foods. Herein, the efficacy of tributyrin (TB), a butyrate analog, encapsulated with ɣ...

Descripción completa

Detalles Bibliográficos
Autores principales: Monaco, Marcia, Lee, Youngsoo, Donovan, Sharon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193825/
http://dx.doi.org/10.1093/cdn/nzac053.058
_version_ 1784726561774108672
author Monaco, Marcia
Lee, Youngsoo
Donovan, Sharon
author_facet Monaco, Marcia
Lee, Youngsoo
Donovan, Sharon
author_sort Monaco, Marcia
collection PubMed
description OBJECTIVES: Inflammatory bowel diseases are common in adults, and their incidence is increasing in children. Butyrate, a short chain fatty acid, can improve gut health, but its bitterness limits incorporation into foods. Herein, the efficacy of tributyrin (TB), a butyrate analog, encapsulated with ɣ-cyclodextrin (ɣ-CD) on growth and intestinal inflammation in a piglet model of dextran-sodium sulfate (DSS)-induced colitis was investigated. METHODS: Two-day-old piglets were randomized to three diets: control (formula alone, CON, N = 41), CD (CON + 9.0 mM ɣ-CD, N = 41), or CDTB (CON + 9.0 mM ɣ-CD/TB, N = 43). Half of the piglets in each group received DSS (1.25 g/kg body weight) from postnatal day (PND) 14 to 18. Blood and intestinal samples were collected on PND 19 and 27. IL-6 and TNF-α concentration in serum and colon mucosa were assessed by ELISA and IL-6, TNF-α, IL-10 and IFN-γ gene expression in colonic tissue were measured by qPCR. A quantitative histological grading system was used to assess 4 independent parameters: epithelial lining, cell infiltration, crypt damage and extent of the intestinal section affected. RESULTS: Average daily weight gain (WG) between PND2-10 and 10–19 were affected by diet (P < 0.05), while colitis led to lower WG from PND19-27. A diet and colitis interaction indicated that after PND22 CDTB-COL piglets weighed less than CON and CD (P = 0.051). Diet had no impact on the descending colon (DC) morphology in the colitis animals, but the severity of the DC inflammation increased from PND19 and 27 (P < 0.0001). TNF-α and IL-6 concentrations were elevated in the ascending colon (AC) at PND19, but by PND27 concentrations were similar to non-colitis levels. A similar pattern was found in the DC, except that IL-6 remained elevated on PND27. IL-6, TNF-α and IFN-γ gene expression were significantly higher in the DC of colitis vs. non-colitis animals on PND27. Diet and colitis had no effect on serum TNF-α and IL-6. CONCLUSIONS: The piglet as a model of DSS colitis is a feasible alternative to rodents. Dietary ɣ-CD/TB reduced growth rate and did not ameliorate the inflammatory process of DSS-induced colitis in neonatal pigs. Herein, oral administration of encapsulated TB did not reduce DSS-induced tissue damage or inflammation, however, additional studies are needed to confirm these observations. FUNDING SOURCES: NIFA, ISDA 2017–67,017-26,519.
format Online
Article
Text
id pubmed-9193825
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-91938252022-06-14 The Efficacy of Encapsulated Gamma-Cyclodextrin/Tributyrin on Growth and Inflammation in a Dextran Sodium Sulfate-Challenge Piglet Model Monaco, Marcia Lee, Youngsoo Donovan, Sharon Curr Dev Nutr Dietary Bioactive Components OBJECTIVES: Inflammatory bowel diseases are common in adults, and their incidence is increasing in children. Butyrate, a short chain fatty acid, can improve gut health, but its bitterness limits incorporation into foods. Herein, the efficacy of tributyrin (TB), a butyrate analog, encapsulated with ɣ-cyclodextrin (ɣ-CD) on growth and intestinal inflammation in a piglet model of dextran-sodium sulfate (DSS)-induced colitis was investigated. METHODS: Two-day-old piglets were randomized to three diets: control (formula alone, CON, N = 41), CD (CON + 9.0 mM ɣ-CD, N = 41), or CDTB (CON + 9.0 mM ɣ-CD/TB, N = 43). Half of the piglets in each group received DSS (1.25 g/kg body weight) from postnatal day (PND) 14 to 18. Blood and intestinal samples were collected on PND 19 and 27. IL-6 and TNF-α concentration in serum and colon mucosa were assessed by ELISA and IL-6, TNF-α, IL-10 and IFN-γ gene expression in colonic tissue were measured by qPCR. A quantitative histological grading system was used to assess 4 independent parameters: epithelial lining, cell infiltration, crypt damage and extent of the intestinal section affected. RESULTS: Average daily weight gain (WG) between PND2-10 and 10–19 were affected by diet (P < 0.05), while colitis led to lower WG from PND19-27. A diet and colitis interaction indicated that after PND22 CDTB-COL piglets weighed less than CON and CD (P = 0.051). Diet had no impact on the descending colon (DC) morphology in the colitis animals, but the severity of the DC inflammation increased from PND19 and 27 (P < 0.0001). TNF-α and IL-6 concentrations were elevated in the ascending colon (AC) at PND19, but by PND27 concentrations were similar to non-colitis levels. A similar pattern was found in the DC, except that IL-6 remained elevated on PND27. IL-6, TNF-α and IFN-γ gene expression were significantly higher in the DC of colitis vs. non-colitis animals on PND27. Diet and colitis had no effect on serum TNF-α and IL-6. CONCLUSIONS: The piglet as a model of DSS colitis is a feasible alternative to rodents. Dietary ɣ-CD/TB reduced growth rate and did not ameliorate the inflammatory process of DSS-induced colitis in neonatal pigs. Herein, oral administration of encapsulated TB did not reduce DSS-induced tissue damage or inflammation, however, additional studies are needed to confirm these observations. FUNDING SOURCES: NIFA, ISDA 2017–67,017-26,519. Oxford University Press 2022-06-14 /pmc/articles/PMC9193825/ http://dx.doi.org/10.1093/cdn/nzac053.058 Text en © The Author 2022. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Dietary Bioactive Components
Monaco, Marcia
Lee, Youngsoo
Donovan, Sharon
The Efficacy of Encapsulated Gamma-Cyclodextrin/Tributyrin on Growth and Inflammation in a Dextran Sodium Sulfate-Challenge Piglet Model
title The Efficacy of Encapsulated Gamma-Cyclodextrin/Tributyrin on Growth and Inflammation in a Dextran Sodium Sulfate-Challenge Piglet Model
title_full The Efficacy of Encapsulated Gamma-Cyclodextrin/Tributyrin on Growth and Inflammation in a Dextran Sodium Sulfate-Challenge Piglet Model
title_fullStr The Efficacy of Encapsulated Gamma-Cyclodextrin/Tributyrin on Growth and Inflammation in a Dextran Sodium Sulfate-Challenge Piglet Model
title_full_unstemmed The Efficacy of Encapsulated Gamma-Cyclodextrin/Tributyrin on Growth and Inflammation in a Dextran Sodium Sulfate-Challenge Piglet Model
title_short The Efficacy of Encapsulated Gamma-Cyclodextrin/Tributyrin on Growth and Inflammation in a Dextran Sodium Sulfate-Challenge Piglet Model
title_sort efficacy of encapsulated gamma-cyclodextrin/tributyrin on growth and inflammation in a dextran sodium sulfate-challenge piglet model
topic Dietary Bioactive Components
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193825/
http://dx.doi.org/10.1093/cdn/nzac053.058
work_keys_str_mv AT monacomarcia theefficacyofencapsulatedgammacyclodextrintributyrinongrowthandinflammationinadextransodiumsulfatechallengepigletmodel
AT leeyoungsoo theefficacyofencapsulatedgammacyclodextrintributyrinongrowthandinflammationinadextransodiumsulfatechallengepigletmodel
AT donovansharon theefficacyofencapsulatedgammacyclodextrintributyrinongrowthandinflammationinadextransodiumsulfatechallengepigletmodel
AT monacomarcia efficacyofencapsulatedgammacyclodextrintributyrinongrowthandinflammationinadextransodiumsulfatechallengepigletmodel
AT leeyoungsoo efficacyofencapsulatedgammacyclodextrintributyrinongrowthandinflammationinadextransodiumsulfatechallengepigletmodel
AT donovansharon efficacyofencapsulatedgammacyclodextrintributyrinongrowthandinflammationinadextransodiumsulfatechallengepigletmodel